Recipelist

Grovet Administrator

  1. Key updates: shortened withdrawal period for OXTRA DD 100 mg/ml

    Product OXTRA DD

    We would like to inform you of important updates regarding the veterinary medicinal product OXTRA DD 100 mg/ml, which impact the withdrawal periods for milk from cattle and sheep.

    Key updates:

    • Withdrawal period for milk from cattle (administered every 24 hours): Previously 144 hours, now reduced to 72 hours.
    • Withdrawal period for milk from sheep (administered every 24 hours): Previously 144 hours, now reduced to 120 hours.

    The withdrawal periods for meat and other species remain unchanged. For further details, please refer to the updated product information available on our website.

    Lire plus »
  2. Increase in Dutch VAT Rate on (supplementary) animal feed from January 1st 2025

    Complementary feed for horses

    Effective January 1st 2025, the VAT rate on a wide range of animal feed and related products will increase from 9% to 21%, as determined by the Dutch Tax Office. This adjustment applies to all complementary feeds, including but not limited to feed supplements, dietary feeds, rearing milk, vitamins, minerals, and other feed additives. Consequently, Grovet is required to implement the new 21% VAT rate for all deliveries made on or after this date.

    It is recommended that invoicing processes be updated accordingly to ensure compliance.

    For further details, please consult the official notice issued by the Dutch Tax Office

    Lire plus »
  3. Big Little Fats; benefits of Omega-3 fatty acids in the Horse

    Omega-3 fatty acids for a healthy horse

    While nutrition has historically been considered the appropriate amount of nutrients needed for energy, to maintain weight and promote growth, the majority of dietary effects may actually occur in ways that are, in fact, not always obvious to the naked eye. This is until there is evidence of a health concern. But what is consumed through the daily diet really begins by influencing at the level of the cell and has a profound effect on each and every living animal. What the horse consumes has the ability to benefit so many areas of health, including immunity, athletic performance, reproduction, metabolism, longevity and more. But what the horse takes in daily also has the ability to interfere or take away from the health and well-being of the animal. A specific fat, the omega-3 fatty acid, has a significant role in equine nutrition due to its multiple applications

    Lire plus »
  4. The New Feeding: A practical handbook for better horse welfare

    The books The New Feeding and The Equinesports Veterinary Manual

    Many of today's equestrian businesses still use, in terms of management and training, methods based on insights from the last century. If we, as a profession, want to continue supporting equestrian sports in a positive way over the next decade, it is essential to revise these methods and provide horse owners with sufficient practical tools to do so.

    The crucial role of proper rations

    Nutrition plays a vital role within managing horse welfare; a proper ration is essential. Although

    Lire plus »
  5. HorStem; world’s first drug based on equine umbilical cord mesenchymal stem cells

    HorStem; world’s first drug based on equine umbilical cord mesenchymal stem cells

    HorStem is the first registered veterinary medicine based on mesenchymal stem cells obtained from the umbilical cord of horses. Stem cells reduce lameness in horses with mild to moderate degenerative joint disease (OA).

    It is a ready-to-use, sterile, injectable suspension for intra-articular use in horses. Each vial contains 15 million active stem cells, more than enough to achieve the minimum effective dose in the joint regardless of the degree of inflammation or the patient's immune system status.

    How does HorStem work?

    The mechanism of action of HorStem is illustrated in the figure on the right. Mesenchymal stem cells are activated in the synovium by inflammatory cytokines. In response, they secrete anti-inflammatory cytokines such as Prostaglandin E2 (PGE2).

    While PGE2 is primarily known for its pro-inflammatory effects, it also plays a crucial role in regulating inflammation. It is one of the major immunomodulatory cytokines in the body.

    When applied to horses with OA, HorStem inhibits T-cell proliferation, reduces the production of pro-inflammatory cytokines like TNF-alpha, and decreases the presence of matrix metalloproteinases (MMPs) that contribute to the breakdown of cartilage's extracellular matrix. Studies have shown that these effects are mediated by PGE2. (1)

    Moreover, umbilical cord-derived mesenchymal stem cells stimulate the production of anti-inflammatory cytokines such as IL-4, IL-5, IL-10, and TGF-beta. As the inflammatory response ceases

    Lire plus »
  6. Zomedica Announces Expansion of Exclusive Equine Distribution Agreement with Grovet in Europe

    Zomedica Announces Expansion of Exclusive Equine Distribution Agreement with Grovet in Europe

    Expansion adds new countries to Grovet's existing PulseVet distribution coverage and enables launch of the TRUFORMA® equine platform in Europe

    ANN ARBOR, MI / ACCESSWIRE / October 3, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced the expansion of its distribution partnership in Europe with Grovet, a leading equine-focused veterinary distributor.

    The terms of the updated agreement offer Grovet equine distribution rights for Zomedica's equine PulseVet® and TRUFORMA product platforms throughout most of Europe. Grovet will exclusively distribute these equine products in 27 countries, including Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary,

    Lire plus »
  7. Meet our team at...

    Meet our team at...

    Meet our team at...

    Oct. 10 to 11

    ESER - BE

    Oct. 24 to 25

    ISELP - FR

    Oct. 26 to 27

    Expovet - BE

    31 oktober t/m 2 november

    Sports Medicine and Rehabilitation Days - NL


    We look forward to meeting you!

    Lire plus »
  8. Advanced orthopedic care and rehabilitation for horses: discover Paniolo and IceHorse

    Ice-Horse & Paniolo products

    At Grovet, you will find a wide range of innovative products for the prevention and rehabilitation of injuries for horses. In this blog, we would like to introduce you to Paniolo and IceHorse, unique brands that contribute to the health of horses.

    Lire plus »
  9. La famille Zoetis de dispositifs de médecine régénérative : Pro-Stride APS, Restigen PRP et CenTrate

    La famille Zoetis de dispositifs de médecine régénérative : Pro-Stride APS, Restigen PRP et CenTrate

    Qu'est-ce que le système Pro-Stride ?

    Pro-Stride, Restigen et CenTrate sont des dispositifs médicaux qui permettent de transformer le sang du cheval en solutions thérapeutiques. En moins de 30 minutes, des solutions de protéines autologues (APS), des PRP et des concentrés d'aspirats de moelle osseuse peuvent être préparés. Le système est adapté à une utilisation ambulatoire et ne nécessite pas d'incubation. Le système est fermé ce qui en fait un processus sûr avec un risque minimal de contamination. 

    Plasma riche en plaques, Restigen PRP

    Le Restigen PRP est principalement utilisé

    Lire plus »
  10. Oxtra DD, the only registered oxytetracycline for horses in Belgium and the Netherlands!

    Oxtra DD, the only registered oxytetracycline for horses in Belgium and the Netherlands!

    Oxtra DD 100 mg/ml Oxytetracycline

    Oxtra DD is an antibiotic for the treatment of infections caused by oxytetracycline-sensitive organisms. Oxtra DD is a solution for injection for horses, cattle, sheep, pigs, dogs and cats. 

    What is Oxtra DD?

    Oxtra DD is a bacteriostatic antibiotic with high bioavailability and a broad antibacterial spectrum of action covering both gram-positive and gram-negative bacteria. Oxtra DD gives good concentrations both in deep tissue and intracellularly. 

    Oxytetracycline inhibits protein synthesis in susceptible bacteria. It binds to the receptors on subunit 30S which prevents the addition of amino acids to the growing peptide chain, thereby inhibiting protein synthesis.    

    Oxtra DD can be administered intramuscularly every 24 hours thanks to its special formulation, either at low doses or at higher doses

    Lire plus »
Page
© 2024 Grovet B.V. All rights reserved.